JK Tyre & Industries Ltd approves expansion of TBR and PCR tyre capacity by 24%
JK Tyre & Industries · Auto Components
Key highlights
- Board approved phased expansion for Truck & Bus Radial (TBR) and Passenger Car Radial (PCR) tyres
- Proposed capacity addition of 24%, totaling 210 lakh tyres per annum by FY 2029-30
- Investment of ₹4,980 crore to be funded through internal accruals and debt sources
Why it's rated notable: the amount is 29% of annual revenue (20% to 50%)
Original filing
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from JK Tyre & Industries
- Board / shareholder meeting outcomeNotableJK Tyre reports FY 2025-26 consolidated revenue up 11% to ₹16,384 crore at 73rd AGM
Other capex / expansion filings this fortnight
- Maharaja & Speedex India Limited raises manufacturing capacity to 72 lakh units/year
- Elin Electronics Q2 FY27 earnings report with 10% revenue growth and margin update
- HOAC Foods India Limited H1 FY27 Earnings Call Transcript dated November 5, 2026
- Gujarat State Fertilizers & Chemicals Limited Q2 FY27 Earnings Call Highlights
- Supriya Lifescience H1 revenue up 14.8% to ₹396.04 crore; Q2 profit falls
- V-MARC India Ltd announces Q2 & H1 FY27 unaudited financial results and review report
Potential multibaggers · Q2 FY27
Potential multibaggers in Auto Components
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.